News

EUDA Health Launches Innovative Immune Supplement for Wellness

EUDA Health Launches Innovative Immune Supplement for Wellness

EUDA Health Unveils a New Era in Immune Wellness

SINGAPORE — EUDA Health Holdings Limited (NASDAQ: EUDA) has taken a significant step forward in its commitment to wellness with the introduction of a next-generation immune health supplement. This groundbreaking product emerges from their wholly-owned subsidiary, EUDA Health Pte. Ltd., which has secured exclusive worldwide distribution rights from Chemokine Pte. Ltd., a forward-thinking biotech firm known for its innovative approach to molecular supplements.

Strategic Market Expansion

The new supplement, named Euda Helixé, will be marketed primarily in Singapore, Malaysia, and China, with plans for future expansion into additional markets. This launch is a substantial enhancement to EUDA's portfolio, reaffirming the company’s mission to reshape the health and wellness landscape across Asia.

Advanced Technology at Work

Euda Helixé is formulated with advanced technology that acts at the molecular level to modulate gene expression, activating beneficial genes while silencing those that may be harmful. This cutting-edge approach not only enhances metabolism and boosts vitality but also supports longevity, positioning the product as a crucial component in EUDA’s expanding array of wellness solutions.

Ingredient Highlights

The formulation boasts a rich blend of premium-grade ingredients, each chosen for their specific health benefits:

  • Deer placenta
  • L-Glutathione
  • Astaxanthin
  • Marine collagen
  • Sea-Buckthorn oil
  • Grape seed oil
  • New Zealand refined avocado oil

This carefully crafted supplement features a capsule delivery system that ensures the active ingredients can survive stomach acid and be absorbed effectively by the body, thereby enhancing its overall efficacy.

Key Benefits of the Euda Helixé Supplement

The Euda Helixé supplement is packed with benefits, which include:

  1. Gene-activated metabolic enhancement for improved health
  2. Sustained energy and vitality provided through a time-release delivery mechanism
  3. Collagen-driven skin regeneration and youthfulness
  4. Support for longevity via stem cell regeneration pathways

The Vision Behind the Innovation

Founded by Professor Kah Meng Lim, recognized for his research in molecular medicine, Chemokine combines deep scientific knowledge with consumer health innovation. Prof. Lim’s extensive background equips him to bridge the gap between academic discoveries and practical health applications, ensuring the Euda Helixé product is both effective and market-ready.

CEO Mr. Alfred Lim expressed enthusiasm about this new supplement, stating that securing exclusive distribution rights represents a significant milestone for EUDA. He believes that the unique qualities of the Euda Helixé will not only diversify their offerings but also pave the way for robust sales, with projections estimating around 500,000 bottles could be sold within a year.

About EUDA Health Holdings Limited

EUDA Health Holdings Limited (NASDAQ: EUDA) stands at the forefront of non-invasive healthcare in Asia, specifically targeting segments in Singapore, Malaysia, and China. With a strategic aim to dominate the preventive healthcare sector, EUDA is set on addressing the healthcare needs of over 1.8 billion people in the region experiencing rapid demographic shifts as more than 30% of the population ages. Through innovative health solutions that blend accessibility with scientific backing, EUDA is reimagining healthcare, shifting from reactive treatments to proactive wellness solutions.

Frequently Asked Questions

What is Euda Helixé?

Euda Helixé is a next-generation immune health supplement aimed at enhancing overall wellness through advanced gene modulation technology.

Who developed Euda Helixé?

The supplement was developed by Chemokine Pte. Ltd., a biotech company led by Professor Kah Meng Lim, an expert in molecular medicine.

Where will Euda Helixé be available?

Initially, Euda Helixé will be marketed in Singapore, Malaysia, and China, with potential plans to expand into other regions.

What are the key benefits of this supplement?

The supplement offers benefits such as metabolic enhancement, sustained energy, skin regeneration, and longevity support.

How does the capsule delivery system work?

The capsule system is designed to protect the active ingredients from stomach acid, ensuring they are effectively absorbed in the body.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 7

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 6

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 8

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading

Top 5 Most Recently Viewed Articles

Credicorp Ltd. Prepares for Upcoming Earnings Announcement

Updated Category News Views 163

Credicorp Ltd. Earnings Release Overview Credicorp Ltd. is set to unveil its financial performance for the third quarter. The eagerly anticipated report will be published on a designated date following market closure, marking a significant moment for investors and stakeholders. Essential Earnings Call Details The live webcast and conference call, where executives will...

Continue Reading
Class Action Lawsuit Seeks Justice for CTO Realty Investors

Updated Category News Views 114

Class Action Lawsuit Against CTO Realty Growth, Inc. Recently, a significant class action lawsuit was filed targeting CTO Realty Growth, Inc. (CTO). The allegations center around the claim that the company misled shareholders regarding the sustainability of its dividends, which were purportedly more fragile than previously conveyed. Furthermore, the lawsuit highlights...

Continue Reading
Remarkable Journey of Conjoined Twin Boys at CHOP Hospital

Updated Category News Views 278

Remarkable Journey of Conjoined Twin Boys at CHOP Hospital Amari and Javar Ruffin, who were born conjoined, are an inspiring example of medical advancement. This case represents Children's Hospital of Philadelphia's 32nd success in separating conjoined twins. Separation Process and Surgical Team After nearly a year at Children's Hospital of Philadelphia (CHOP), Amari and...

Continue Reading
Ternium's Q4 Earnings Miss: What's Next for TX Investors?

Updated Category News Views 128

Ternium (NYSE:TX) dropped its Q4 earnings bombshell on February 18, 2026, and let's be real: it wasn't pretty. The company reported an EPS of $0.62—down a staggering 19.48% from estimates that had analysts betting on $0.77. That’s not just a miss; it’s like overshooting the target by a mile in the middle of a game-winning drive. Revenue Plunge: A Red Flag or Just...

Continue Reading
Revolutionary Breakthrough: FDA Approves Itvisma for SMA Treatment

Updated Category News Views 435

FDA Approves Itvisma for Spinal Muscular Atrophy Treatment In a remarkable development, the FDA has approved Itvisma (onasemnogene abeparvovec-brve), marking a significant milestone in the treatment of spinal muscular atrophy (SMA). This breakthrough therapy is the only gene replacement option for individuals aged two years and above, including children, teens, and adults...

Continue Reading